Scientific Advisory Board
Edward Chu, MD
Chair, Professor of Medicine, Pharmacology & Chemical Biology at the University of Pittsburgh School... Show More
...of Medicine; Chief of the Division of Hematology-Oncology in the Department of Medicine at the University of Pittsburgh School of Medicine; Deputy Director of the University of Pittsburgh Cancer Institute (UPCI); and Leader of the UPCI Molecular Therapeutics and Drug Discovery Program. Prior to his position at the University of Pittsburgh, Dr. Chu served as Deputy Director of the Yale Cancer Center and the Yale University School of Medicine.
Joseph R. Bertino, MD
Associate Director At The Cancer Institute Of New Jersey And Professor Of Medicine And Pharmacology ... Read More
... at the University of Medicine and Dentistry of New Jersey – Robert Wood Johnson Medical School. Dr. Bertino was formerly Head of the Yale Cancer Center and more recently Chairman of Molecular Pharmacology and Therapeutics Program at the Sloan-Kettering Institute for Cancer Research.
Alec Goldenberg, MD
Director, Hematology Clinic and Hepatoma Tumor Study Group, Bellevue Hospital, New York University M... Read More
...Medical Center; Clinical Associate Professor of Medicine, New York University School of Medicine; and clinical practitioner. Dr. Goldenberg has 20 years combined experience in clinical oncology practice with Memorial Sloan-Kettering and New York University.
Li Zhang, MD
Professor of Medical Oncology and Deputy Director of Lung Cancer Research Centre at Sun Yat-Sen Univ... Read More
...University; Chief of the Department of Medical Oncology and Associate Director of the National Anti-Cancer Drug Clinical Research Centre at the Sun Yat-Sen University Cancer Centre in Guangzhou, China. Dr. Zhang also serves on the Board of the International Association for the Study of Lung Cancer, vice chairman of the Association of Rehabilitation and Palliative Care and vice chairman of both the Cancer Chemotherapy Association and Lung Cancer Association of the Guangdong Province, China.
Howard McLeod, PharmD
Dr. Howard McLeod is the Medical Director of the DeBartolo Family Personalized Medicine Institute at... Read More
...at the Moffitt Cancer Center. He is also a Senior Member of the Division of Population Sciences. He is a Professor at the University of South Florida College of Medicine and Pharmacy. Most recently, he was the Fred Eshelman Distinguished Professor and Founding Director of the UNC Institute for Pharmacogenomics and Individualized Therapy, University of North Carolina, Chapel Hill. Dr. McLeod is chair of the NHGRI eMERGE network external scientific panel and a recent member of the FDA committee on Clinical Pharmacology. He is a member of the NIH NHGRI Advisory Council. Since 2002, Dr. McLeod has been vice chair for Pharmacogenomics for the NCI clinical trials cooperative group CALGB/ALLIANCE, overseeing the largest oncology pharmacogenomics portfolio in the world. Dr. McLeod is also a 1000 talent scholar of China and a Professor at Central South University in Changsha, China. He also directs the Pharmacogenetics for Every Nation Initiative, which aims to help developing countries use local clinical pharmacology information to improve National Drug Formulary decisions. Howard has published over 470 peer reviewed papers on pharmacogenomics, applied therapeutics, or clinical pharmacology and continues to work to integrate individualized therapy principles into clinical practice to advance personalized medicine.
Joanne Spadoro, Ph. D.
Dr. Spadoro has held a number of leadership positions within the molecular diagnostics and medical device industries... Read More
She spent 19 years at Roche Molecular Systems where she was Senior Vice President of Global Product Development and Operations. While at Roche, Dr. Spadoro was responsible for the development of the first PCR based infectious disease tests commercialized worldwide. Dr. Spadoro then joined Immucor, where she held positions as Chief Scientific Officer, General Manager of BioArray Solutions, and Vice President of Worldwide Manufacturing. At Immucor, Dr. Spadoro led the development of the first FDA approved test in the field of molecular immunohematology. Dr. Spadoro currently is an advisor in the molecular diagnostic / medical device fields.
Dr. Spadoro received a B.A. in biological sciences from Douglass College and a Ph.D. in cell biology from the University of Connecticut.